Evaluating PCR Tests for Detecting Human Cytomegalovirus in Immunocompromised Patients
Author Information
Author(s): Sowmya P, Madhavan HN, Therese KL
Primary Institution: L & T Microbiology Research Center, Vision Research Foundation, Chennai, India
Hypothesis
Can different PCR tests effectively detect HCMV DNA in clinical specimens from immunocompromised patients?
Conclusion
The study found that PCR targeting the mtr II region is the most effective method for detecting HCMV DNA in immunocompromised patients in Chennai, India.
Supporting Evidence
- The PCR for mtr II region showed 100% sensitivity and negative predictive value.
- Of the 48 specimens positive by the gold standard, all were positive for mtr II PCR.
- The increase in clinical sensitivity for mtr II over UL 83 and gO PCRs was statistically significant.
Takeaway
Doctors can use a special test called PCR to find a virus called HCMV in sick patients, and one specific test works the best.
Methodology
The study evaluated three PCR tests on 92 clinical specimens from 74 immunocompromised patients, using pp65 antigenemia as the gold standard.
Limitations
The study may not be generalizable to other regions due to specific local factors.
Participant Demographics
Among the 74 patients, 47 were males and 27 females, with ages ranging from newborns to 67 years.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website